Human Fetuses Can Contract SARS-CoV-2, but It’s Rare

Compared with Zika and cytomegalovirus, the virus that causes COVID-19 appears to have a harder time penetrating the placenta and moving to a woman’s unborn baby.

Written byAshley Yeager
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

ABOVE: MODIFIED FROM © ISTOCK.COM, ELENA MAKEEVA

Drucilla Roberts and Vanda Torous stared at the placental tissue of two babies—fraternal twins—and were stunned by what they saw. The twins had shared the same womb and obviously the same mother, who’d tested positive for SARS-CoV-2 during delivery, yet the babies’ individual placentas looked very different, Roberts recalls. The tissue of one of the placentas was severely inflamed, riddled with immune cells. The other one looked healthy. When Roberts and Torous, who are both pathologists at Massachusetts General Hospital in Boston, ordered tests of the placental tissue for markers of SARS-CoV-2, the inflammation-riddled organ appeared to be heavily infected with the virus, while the other one had relatively little viral RNA.

Neither twin tested positive for the novel coronavirus after birth, Roberts tells The Scientist. “The babies are fine.” The fact that one placenta was heavily infected by the virus and severely ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

    View Full Profile

Published In

January 2021

Expecting and Infected

What science is revealing about COVID-19 in mothers to be

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies